Position in EXEL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$432,502
+$105,925 QoQ
Shares Held
10,084
+35.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $21,501,509 across 296 Biotechnology names. EXEL ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
15,803 | $7,056,671 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
36,244 | $2,342,449 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,991 | $2,310,966 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,562 | $1,864,600 | |
| 5 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
26,462 | $655,199 | |
| 6 | CRSP |
CRISPR Therapeutics AG
|
11,016 | $524,031 | |
| 7 | INCY |
Incyte Corp
|
4,834 | $454,976 | |
| 8 | EXEL |
Exelixis, Inc.
This page
|
10,084 | $432,502 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $432,502 | 10,084 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $326,577 | 7,451 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $118,489 | 2,869 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $73,525 | 1,668 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $26,250 | 711 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $21,045 | 632 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $9,809 | 378 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $13,167 | 586 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $10,251 | 432 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $10,075 | 420 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,751 | 309 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $4,834 | 253 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $26,048 | 1,342 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $5,084 | 317 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $5,550 | 354 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,809 | 231 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $16,685 | 736 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $9,798 | 536 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $422 | 20 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $364 | 20 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $451 | 20 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $401 | 20 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $489 | 20 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $474 | 20 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $344 | 20 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||